HALO logo
halo search icon
Novo Nordisk A/S Sponsored ADR Class B

US$45.07

Price Change Indicator
0.79 (1.78%)
Novo Nordisk A/S Sponsored ADR Class B
NVO · NYS

Novo Nordisk A/S Sponsored ADR Class B

Start Trading NVO for Free

US$45.07

Price Arrow0.79 (1.78%)
20/05/2026 04:10:00 PM
All-ConsensusALL-RecommendationsHammer Bearish (Realtime)Hammer Bullish
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Novo Nordisk A/S Sponsored ADR Class B Overview

NVO Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Very Strong

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Very Weak

Earnings

Very Weak

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About NVO

icon
icon

Telephone

45.44.44.88.88

icon

Address

Novo Allé 1, Bagsværd, Capital Region 2880

Description

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

NVO Price Chart

Key Stats

Market Cap

US$151.25B

PE

14.60

EV/EBITDA

10.7

Dividends Overview

DIV Yield

2.5%

Franking

N/A

Ex Dividend Date (est.)

30-Mar-26

Market Data

52 weeks range

Low 35.12 - 81.44

Trade Value (12mth)

US$226,266,419.00

1 week

-1.03%

1 month

12.33%

YTD

-15.48%

1 year

-35.07%

All time high

148.15

Key Fundamentals

EPS 3 yr Growth

101.40%

EBITDA Margin

48.40%

Operating Cashflow

$18,010m

Free Cash Flow Return

44.10%

ROIC

38.00%

Interest Coverage

35.40

Quick Ratio

0.60

Other Data

Shares Outstanding (Fully Diluted)

4,449m

HALO Sector

Healthcare

Next Company Report Date

03-Feb-27

Next Ex Dividend Date

30-Mar-26

Next Dividend Pay Date

08-Apr-26

Reporting Currency

USD

Short Sell (% of issue)

0.00

NVO Announcements

Latest Announcements

DateAnnouncements
19 May 26
13 May 26
06 May 26
05 May 26
27 April 26

NVO Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
 $locklocklocklock2.713.293.49locklocklock
EPS (Fully Diluted)
 $locklocklocklock2.73.283.48locklocklock
Growth
 %locklocklocklock56.421.46locklocklock
PE
 Xlocklocklocklock38.226.214.6locklocklock
EV/EBITDA
 Xlocklocklocklock28.718.410.7locklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

30-Mar-26

DIV Yield

2.5%

Franking Level

N/A

DPSg

8.8%

Quality Yield

lock

Falling Divs over next 2

lock

Expected Dividend Cashflow

Dividend Clarity,
Enhanced
Strategy

Upload your portfolio and gain access to 3-year dividend forecasts for each holding with HALO Global. Empower your decision-making and maximize returns with our advanced analytical tool. Try it today.

Want to learn more?Frequently asked questions.
What is the current share price of Novo Nordisk A/S Sponsored ADR Class B (NVO:NYS)?
Halo FAQ
The current share price of Novo Nordisk A/S Sponsored ADR Class B (NVO:NYS) is USD$45.07.
What is the 52-week high share price for Novo Nordisk A/S Sponsored ADR Class B (NVO:NYS)?
Halo FAQ
The 52-week high share price for Novo Nordisk A/S Sponsored ADR Class B (NVO:NYS) is USD$81.44.
What is the 52-week low share price for Novo Nordisk A/S Sponsored ADR Class B (NVO:NYS)?
Halo FAQ
The 52-week low share price for Novo Nordisk A/S Sponsored ADR Class B (NVO:NYS) is USD$35.12.
What is the dividend yield for Novo Nordisk A/S Sponsored ADR Class B (NVO:NYS)?
Halo FAQ
The current TTM dividend payout for Novo Nordisk A/S Sponsored ADR Class B (NVO:NYS) is 2.50.
What was Novo Nordisk A/S Sponsored ADR Class B (NVO:NYS) last dividend payment?
Halo FAQ
The last dividend payment of Novo Nordisk A/S Sponsored ADR Class B (NVO:NYS) is USD$0.87.
What is the franking level for Novo Nordisk A/S Sponsored ADR Class B (NVO:NYS)?
Halo FAQ
Novo Nordisk A/S Sponsored ADR Class B (NVO:NYS) has a franking level of 0.00%.
In which sector is Novo Nordisk A/S Sponsored ADR Class B (NVO:NYS) classified?
Halo FAQ
Novo Nordisk A/S Sponsored ADR Class B (NVO:NYS) is classified in the Healthcare.
What is the price-to-earnings (P/E) ratio for Novo Nordisk A/S Sponsored ADR Class B (NVO:NYS)?
Halo FAQ
The current P/E ratio for Novo Nordisk A/S Sponsored ADR Class B (NVO:NYS) is 14.60.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial